IP Verse

Bayer Pharma Aktiengesellschaft opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Bayer Pharma Aktiengesellschaft

Patent Number:
EP2832350
Title:
Method For Producing Disintegrating Particulate Composition Comprising Acid-Type Carboxymethylcellulose, Disintegrating Particulate Composition Comprising Acid-Type Carboxymethylcellulose, And Orally Disintegrating Tablet Including Disintegrating Particulate Composition Comprising Acid-Type Carboxymethylcellulose
Applicant:
DAICEL CORPORATION
Opposition Date:
Apr 16, 2020
Patent Number:
EP3092226
Title:
Indazole Compounds As Irak4 Inhibitors
Applicant:
AURIGENE DISCOVERY TECHNOLOGIES LIMITED
Opposition Date:
Dec 11, 2019
Patent Number:
EP2926142
Title:
Identification Of Patients In Need Of Pd-L1 Inhibitor Cotherapy
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Aug 7, 2019
Patent Number:
EP2794635
Title:
Ion Exchange Membrane Chromatography
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Jun 12, 2019
Patent Number:
EP2462158
Title:
Method To Improve Virus Removal In Protein Purification
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Oct 10, 2018
Patent Number:
EP2322153
Title:
Use Of Hif Alpha Stabilizers For Enhancing Erythropoiesis
Applicant:
FIBROGEN, INC.
Opposition Date:
Jul 8, 2015

Latest patents of Bayer Pharma Aktiengesellschaft opposed by its competitors

Patent:
EP2040683
Grant Date:
Aug 16, 2023
Title:
Pharmaceutical Composition Containing A Tetrahydrofolic Acid
Oppositions:
1
Patent:
EP3325013
Grant Date:
Jul 19, 2023
Title:
Stimulators And/Or Activators Of Soluble Guanylate Cyclase (Sgc) In Combination With An Inhibitor Of Neutral Endopeptidase (Nep Inhibitor) And/Or An Angiotensin Aii Antagonist And The Use Thereof
Oppositions:
1
Patent:
EP3611169
Grant Date:
Jul 21, 2021
Title:
New Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging
Oppositions:
1
Patent:
EP3303307
Grant Date:
Sep 4, 2019
Title:
New Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging
Oppositions:
1
Patent:
EP3206873
Grant Date:
Dec 12, 2018
Title:
Laminate Changing Device
Oppositions:
1
Patent:
EP1747001
Grant Date:
Oct 10, 2018
Title:
Management Of Breakthrough Bleeding In Extended Hormonal Contraceptive Regimens
Oppositions:
2
Patent:
EP2216056
Grant Date:
Aug 22, 2018
Title:
Medical Device For Dispensing Medicaments
Oppositions:
5
Patent:
EP1857127
Grant Date:
Nov 8, 2017
Title:
Bolloon Catheter For Paclitaxel-Release
Oppositions:
4
Patent:
EP2099453
Grant Date:
Sep 6, 2017
Title:
Combination Therapy Of Substituted Oxazolidinones
Oppositions:
9
Patent:
EP2216055
Grant Date:
Jul 26, 2017
Title:
Medical Device For Dispensing Medicaments
Oppositions:
5

Competitors of Bayer Pharma Aktiengesellschaft

BECTON, DICKINSON AND COMPANY

BOSTON SCIENTIFIC CORPORATION

COOK MEDICAL TECHNOLOGIES LLC

Want to track Bayer Pharma Aktiengesellschaft?

Feel free to send us a message here and we will get back to you